Neurofibromatosis Type 1 Revisited
Top Cited Papers
- 1 January 2009
- journal article
- review article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 123 (1), 124-133
- https://doi.org/10.1542/peds.2007-3204
Abstract
Neurofibromatosis type 1 (NF1) is an autosomal dominant condition with a worldwide incidence of ∼1 per 2500 to 3000 individuals. Caused by a germ-line–inactivating mutation in the NF1 gene on chromosome 17, the disease is associated with increased morbidity and mortality. In the past several years, significant progress has been made in standardizing management of the major clinical features of neurofibromatosis type 1. Moreover, improved understanding of how the neurofibromatosis type 1 protein, neurofibromin, regulates cell growth recently provided insight into the pathogenesis of the disease and has led to the development of new therapies. In this review, we describe the clinical manifestations, recent molecular and genetic findings, and current and developing therapies for managing clinical problems associated with neurofibromatosis type 1.Keywords
This publication has 67 references indexed in Scilit:
- Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1–like phenotypeNature Genetics, 2007
- Tumor microenvironment and neurofibromatosis type I: connecting the GAPsOncogene, 2007
- Bone Mineral Density in Children and Adolescents with Neurofibromatosis Type 1The Journal of Pediatrics, 2007
- AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma PatientsCancer Cell, 2007
- Guidelines for the diagnosis and management of individuals with neurofibromatosis 1Journal of Medical Genetics, 2006
- Harnessing preclinical mouse models to inform human clinical cancer trialsJCI Insight, 2006
- Review Article : Genetics of Neurofibromatosis 1 and the NF1 GeneJournal of Child Neurology, 2002
- Tumorigenic Properties of Neurofibromin-Deficient Neurofibroma Schwann CellsThe American Journal of Pathology, 2001
- Natural history of optic pathway tumors in children with neurofibromatosis type 1: A longitudinal studyThe Journal of Pediatrics, 1994
- Neurofibromatosis type 1: The cognitive phenotypeThe Journal of Pediatrics, 1994